Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-03-06

Clinical Trial Update: Phenylbutyrate Therapy for Maple Syrup Urine Disease [Phase 2, Phase 3]

View source ↗

Summary

Phase 2 and Phase 3 trial update for phenylbutyrate therapy in Maple Syrup Urine Disease with completed status and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • phenylbutyrate therapy (phenylbutyrate)

Snippet

Sponsor: Brendan Lee | Conditions: Maple Syrup Urine Disease | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2019-03-06